Literature DB >> 31238187

Imaging findings in epithelioid hemangioendothelioma.

Yan Epelboym1, Dawn R Engelkemier1, Frederic Thomas-Chausse1, Ahmad I Alomari2, Alyaa Al-Ibraheemi3, Cameron C Trenor4, Denise M Adams4, Gulraiz Chaudry5.   

Abstract

PURPOSE-
OBJECTIVE: Epithelioid hemangioendothelioma (EHE) is a rare vascular malignancy with varying biologic behavior. The purpose of this study was to identify imaging findings most characteristic of EHE.
METHODS: Retrospective review of clinical and imaging records in patients referred to our Vascular Anomalies Center over a 17 year period with biopsy proven EHE.
RESULTS: We evaluated 29 patients (17 F) with median age of 16 years (range 2-76 y). The most common presenting symptoms were pain (n = 13) and palpable mass (n = 7). 22 (70%) had multifocal disease. Most common sites of involvement were lung (n = 25), liver (n = 16), bone (n = 12), soft tissue (n = 3) and lymph nodes (n = 1). Of patients with single site disease, 3 had lung, 3 liver, and 1 had bone lesions. In 18/25 with lung disease, there were multiple nodules of varying sizes and characteristics. In 14/16 with hepatic disease there were multiple nodules with predominantly peripheral distribution. Subcapsular retraction was seen in 10/16 and a "lollipop" sign (hepatic or portal vein tapering at the edge of a well-defined hypoenhancing lesion) identified in 5/16. Of 12 osseous lesions, 11 were lytic, 8 involved vertebrae and 9 involved the axial skeleton.
CONCLUSION: EHE has varied imaging findings. The most common sites are lungs, liver, and bone, with multi-organ involvement seen in most. Lung disease is most commonly characterized by multiple nodules. Hepatic lesions demonstrate the most distinctive findings, with peripheral distribution, lack of early enhancement, subcapsular retraction and "lollipop" sign. Osseous lesions are commonly lytic and more prevalent in the axial skeleton.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epithelioid hemangioendothelioma; Pediatrics; Radiology

Mesh:

Year:  2019        PMID: 31238187     DOI: 10.1016/j.clinimag.2019.06.002

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  5 in total

1.  Case Report: 18F-FDG PET/CT Demonstrating Malignant Spread of a Pulmonary Epithelioid Hemangioendothelioma.

Authors:  Ruolin Wu; Xiaotian Xia; Fan Hu; Yajing Zhang; Jingjing Wang; Yong He; Zairong Gao
Journal:  Front Med (Lausanne)       Date:  2022-04-04

2.  Primary splenic epithelioid hemangioendothelioma with diffuse metastases revealed by FDG PET/CT imaging: A case report.

Authors:  Xian Li; Xiaowei Ma; Jingwen Hao; Chuning Dong; Yunhua Wang
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

3.  A Rare Hepatic Epithelioid Hemangioendothelioma in a Cirrhotic Liver.

Authors:  Lan Zhang; Yanru Zhou; Jiajia Zhang
Journal:  Balkan Med J       Date:  2021-11       Impact factor: 2.021

4.  Novel and Specific MRI Features Indicate the Clinical Features of Patients With Rare Hepatic Tumor Epithelioid Hemangioendothelioma.

Authors:  Wei Zhang; Hongtao Zhang; Yanwei Zhong; Keming Zhang; Huifang Kong; Linxiang Yu; Yan Chen; Yili Bai; Zhenyu Zhu; Yongping Yang; Xudong Gao
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

Review 5.  Hepatic Hemangioendothelioma: An update.

Authors:  Mayur Virarkar; Mohammed Saleh; Radwan Diab; Melissa Taggart; Peeyush Bhargava; Priya Bhosale
Journal:  World J Gastrointest Oncol       Date:  2020-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.